TotalMarketCap

Viking Therapeutics

VKTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.289 B

$25.80 -7.78%

Close of 6 Nov 2026

As of 6 Nov 2026, Viking Therapeutics (VKTX) has a market capitalization of $3.29B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$359.6M

Loss-making

Shares outstanding

127,522,189

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #68Arcutis BiotherapeuticsARQT$3.42B
  2. #69Parabilis MedicinesPBLS$3.41B
  3. #70Viking TherapeuticsVKTX$3.29B
  4. #71Enliven TherapeuticsELVN$3.28B
  5. #72Dyne TherapeuticsDYN$3.25B

What if Viking Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$221,427.14

Per share 8,584× higher

Bitcoin $1.53T

$11,981.04

Per share 464× higher

Apple $5.02T

$39,332.63

Per share 1,525× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Viking Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.